An alternative is to target the mechanism responsible for mediating the Notch-induced tumor-suppressing phenotype of MAFs through the utilization of the Notch pathway downstream targets, for example, WISP-1 [9, 11, 31]. The gene discussed is CCN4; the disease is neoplasm.